Bistervels Ingrid M, Buchmüller Andrea, Tardy Bernard
Department of Vascular Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, Netherlands.
Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam, Netherlands.
Front Cardiovasc Med. 2022 Nov 7;9:1026002. doi: 10.3389/fcvm.2022.1026002. eCollection 2022.
Potential hazards of vena cava filters include migration, tilt, perforation, fracture, and in-filter thrombosis. Due to physiological changes during pregnancy, the incidence of these complications might be different in pregnant women.
To evaluate the use and safety of inferior vena cava filters in both women who had an inferior vena cava filter inserted during pregnancy, and in women who became pregnant with an inferior vena cava filter .
We performed two searches in the literature using the keywords "vena cava filter", "pregnancy" and "obstetrics".
The literature search on women who had a filter inserted during pregnancy yielded 11 articles compiling data on 199 women. At least one filter complication was reported in 33/177 (19%) women and included in-filter thrombosis ( = 14), tilt ( = 6), migration ( = 5), perforation ( = 2), fracture ( = 3), misplacement ( = 1), air embolism ( = 1) and allergic reaction ( = 1). Two (1%) filter complications led to maternal deaths, of which at least one was directly associated with a filter insertion. Filter retrieval failed in 9/149 (6%) women. The search on women who became pregnant with a filter resulted in data on 21 pregnancies in 14 women, of which one (6%) was complicated by uterine trauma, intraperitoneal hemorrhage and fetal death caused by perforation of the inferior vena cava filter.
The risks of filter complications in pregnancy are comparable to the nonpregnant population, but could lead to fetal or maternal death. Therefore, only in limited situations such as extensive thrombosis with a contraindication for anticoagulants, inferior vena filters should be considered in pregnant women.
下腔静脉滤器的潜在危害包括移位、倾斜、穿孔、断裂和滤器内血栓形成。由于孕期生理变化,这些并发症在孕妇中的发生率可能有所不同。
评估孕期植入下腔静脉滤器的女性以及植入下腔静脉滤器后怀孕的女性使用下腔静脉滤器的情况及安全性。
我们使用关键词“下腔静脉滤器”“妊娠”和“产科”在文献中进行了两次检索。
关于孕期植入滤器女性的文献检索得到11篇文章,汇总了199名女性的数据。在177名女性中有33名(19%)报告了至少一种滤器并发症,包括滤器内血栓形成(n = 14)、倾斜(n = 6)、移位(n = 5)、穿孔(n = 2)、断裂(n = 3)、位置不当(n = 1)、空气栓塞(n = 1)和过敏反应(n = 1)。2例(1%)滤器并发症导致孕产妇死亡,其中至少1例与滤器植入直接相关。9/149名(6%)女性滤器取出失败。关于植入滤器后怀孕女性的检索得到了14名女性21次妊娠的数据,其中1例(6%)并发子宫创伤、腹腔内出血和下腔静脉滤器穿孔导致的胎儿死亡。
孕期滤器并发症的风险与非孕期人群相当,但可能导致胎儿或孕产妇死亡。因此,仅在有限的情况下,如广泛血栓形成且有抗凝禁忌证时,才应考虑为孕妇植入下腔静脉滤器。